polyacrylamide gel electrophesb. I m m h 9: 709, 1972 Dr. Henwm: When we presented our somewhat similar findings at the ATS meetings, the first question asked by Dr. Ward related to the possible presence of endotoxin in our instillates. This is obviously something you're c o n m e d about. It might be worth your making a comment about it since the question of initiating the cleavage of C5 is of some interest. Dr. Kreutzer: Everything that we instin into the lungs of the hamsters we a d p e by limnlns Iysate routinely whether it's a C5 fragment or wbob C5 we find 10-25 nanograms endotoxin equhahts/ml. We also find in our control substances, aIbumin or I s , a similar content of endotoxin. So it implies that emdotoxin per se, in mixtures of proteins, will not induce the reaction. We've also taken endotoxins both crude and m various degrees of purity, and instilled them in the lungs of the hamsters in the range of picogram through microgram quantities, and have not been able to induce any acute inflammatory reaction m the hamster hmg.
in mixtures of proteins, will not induce the reaction. We've also taken endotoxins both crude and m various degrees of purity, and instilled them in the lungs of the hamsters in the range of picogram through microgram quantities, and have not been able to induce any acute inflammatory reaction m the hamster hmg.
Dr.
&lander: This is a most surprising d. We have been studying tbe efFect of inhaled endotaxins m a variety of animal species, using the increase in the leukocyte number in the hmg as tbe index. At the concentrations that you indicated we get a regular increase of lehcytes m the hmgs of guinea pigs, ham sters, rats and rabbits; so there clearly must be some discrepancy. Dr. Kreutzer: We're aware of papers that indicated aerosol endotoxin caused these reacths. We were instilling it tnwtracheally. A . I can say is that in the hamster we were unable to induce signifkant poly influx at various doses of endotoxin using both crude and p d e d endotoxins which were prepared in different -ys* Dr. Ward: There might be a siPnificant species difference among the animals with which you've been working.
Dr. RyZader: I don't think it's a species Merence. We worked with hamsters as wen as with rabbits and mice to make sure that the reaction we studied was not speciesspecific. It may be that intmtrachd instihtion is the difference. lated a casual pathogenetic relationship between intravascular immunoglobulins and pulmonary interstitial disease. Tomasi and colleagues7 felt that precipitation of insoluble antigen-antibody complexes in the pulmonary capillary bed and interstitium might prove to be a pathogenetic mechanism for pulmonary disease. Brentjens et als demonstrated interstitial lung disease in animals following production of circulating immune complexes.
The purpose of this study was to determine if immune complexes are present in the lung tissue of patients with difhse pulmonary interstitial disease, pulmonary fibrosis and interstitial disease associated with autoimmune diseases in order to determine whether there is a possibility that immune complexes may play a role in the genesis of pulmonary disease. Lung tissue from 38 patients studied by direct immunofluorescent techniques fell into four groups. The first three groups included active interstitial pneumonias (seven), Pneumocystis caring pneumonitis ( 11 ) , interstitial pneumonitis associated with autoimmune diseases (eight) and the fourth group, end-stage pulmonary fibrosis (12).
Our results revealed striking immunofluorescent deposition with conjugated anti-IgG, IgM and IgA antibody in the presence of p,C deposits in all seven patients with active interstitial pneumonias of unknown etiology. Albumin was present in three. IgD and IgE were absent. In a second group of 11 patients with Pneumocystis can'nii pneumonia, seven had a combination of IgG or IgA associated with the deposition of complement. Albumin, IgD and IgE were not present. In a third group consisting of eight patients with active interstitial disease associated with collagen-vascular disease, IgG, IgM, IgA and complement were present in every case. Albumin was found in one case and IgD and IgE in none.
Immunoglobulins G, M and A were present less frequently and found with complement only in one of 12 patients in the pulmonary fibrosis group.
The immuno@bulins and complement were found in di&lse or focal patterns on the thickened interstitium. There were no p e r i v d or peribrmcheal d-ts.
In active interstitial pulmonary disease, striking immunofluorescent deposition was found with conjugated anti-IgG, anti-IgM, anti-IgA and anti-complement in every patient with interstitial pneumonitis, in 82 percent (9/11) of the patients with Pneumocytis carinii pneumonias and in all eight cases with pulmonary interstitial disease associated with the collagen-vascular diseases (systemic lupus and rheumatoid arthritis). The pattern of deposition was coarsely granular throughout the interstitium.
The data suggest that immune complexes consisting of IgG, IgM or IgA have a propensity to be phagocytized by endothelial cells and macrophages or to be found on the phospholipid-containing cell or basement membranes. Because complement is present, it is possible that at the cell membrane adsorption results in complement hation, which could result in infiammation and cell lysis. The presence of increased cellularity and antibody suggests an alternate pathogenic mechanism utilizing antibody-dependent cell mediated toxicity.
In the group of patients with pulmonary fibrosis, immunoglobulins were associated with complement in 8 percent of the patients. Immunoglobulins G, M or A were present in five of 12 patients with puknonary fibrosis, whereas in active interstitial pneumonia, 25 patients had positive I F deposits and only one did not (Chi square = 14.7; P < .001). The immune complexes and complement were present during the active prefibrotic stage of pulmonary interstitial disease, but were iufrequently present together in end-stage pulmonary fibrosis.
The literature suggests that immunoglobulins G and M are present with complement on lung tissue in patients with d h e pulmonary interstitial disease associated with systemic lupus or rheumatoid arthritis. Our data revealed that immunoglobulins and complement were present in patients with other active pulmonary interstitial diseases, such as Pneumocystis carinii pneumonia, the usual interstitial pneumonias, as well as pulmonary interstitial disease associated with the collagen vascular diseases.
The presence of both immunoglobulins and complement in the pulmonary interstitium of patients with active pneumonitis supports the proposal that the pulmonary disorder is in part immunologic in origin. tissue diseases compared to t h e that had idiopathic pneumonia without other disease?
Dr. E i m h r g : No, we did not. We found deposition in the interstitium in all these groups except for pulmonary fibrosis; we feel that this may be a function of time. We have looked previously at a group of NZB/W mice which developed a hxpus-like syndrome. In the young mice, there is an immunoglobulin deposition which is totally vascular; as the mice get older it is throughout the interstitium.
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